JP2004505113A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004505113A5 JP2004505113A5 JP2002516326A JP2002516326A JP2004505113A5 JP 2004505113 A5 JP2004505113 A5 JP 2004505113A5 JP 2002516326 A JP2002516326 A JP 2002516326A JP 2002516326 A JP2002516326 A JP 2002516326A JP 2004505113 A5 JP2004505113 A5 JP 2004505113A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- composition according
- nucleic acid
- composition
- acid encoding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004169 proteins and genes Human genes 0.000 claims 8
- 108090000623 proteins and genes Proteins 0.000 claims 8
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 229920001184 polypeptide Polymers 0.000 claims 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- 230000001105 regulatory effect Effects 0.000 claims 4
- 239000012634 fragment Substances 0.000 claims 2
- 241000700588 Human alphaherpesvirus 1 Species 0.000 claims 1
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 claims 1
- 229940116224 behenate Drugs 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 239000013603 viral vector Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22102500P | 2000-07-27 | 2000-07-27 | |
| PCT/US2001/023648 WO2002010410A1 (en) | 2000-07-27 | 2001-07-27 | Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004505113A JP2004505113A (ja) | 2004-02-19 |
| JP2004505113A5 true JP2004505113A5 (enExample) | 2005-04-07 |
Family
ID=22826021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002516326A Abandoned JP2004505113A (ja) | 2000-07-27 | 2001-07-27 | 単純疱疹ウイルス糖蛋白質ｄを用いた組成物及びそれを用いて免疫応答を抑制する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7569218B2 (enExample) |
| EP (1) | EP1305435B1 (enExample) |
| JP (1) | JP2004505113A (enExample) |
| AT (1) | ATE381351T1 (enExample) |
| AU (2) | AU8467201A (enExample) |
| CA (1) | CA2417364A1 (enExample) |
| DE (1) | DE60131975T2 (enExample) |
| WO (1) | WO2002010410A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120027841A1 (en) * | 2004-01-07 | 2012-02-02 | Biomedical Research Models, Inc. | Novel mucosal vaccination approach for herpes simplex virus type-2 |
| US7717271B2 (en) * | 2005-12-07 | 2010-05-18 | General Electric Company | Membrane structure and method of making |
| US20070131609A1 (en) * | 2005-12-08 | 2007-06-14 | General Electric Company | Membrane structure and method of making |
| US8207854B2 (en) * | 2009-02-09 | 2012-06-26 | Mach 1 Development, Inc. | Shipping container integrity device and system |
| RU2585961C9 (ru) * | 2009-05-22 | 2016-12-27 | Дженосеа Биосайенсиз Инк. | Вакцины против вируса простого герпеса 2 типа: композиции и способы запуска иммунного ответа |
| JP6055776B2 (ja) | 2010-11-24 | 2016-12-27 | ジェノセア バイオサイエンシーズ， インコーポレイテッド | 単純ヘルペスウイルス２型に対するワクチン：免疫応答を誘発する組成物及び方法 |
| JP6199878B2 (ja) | 2011-11-23 | 2017-09-20 | ジェノセア バイオサイエンシーズ， インコーポレイテッド | 単純ヘルペスウイルス２型に対する核酸ワクチン：免疫応答を誘発する組成物及び方法 |
| EP3519427A4 (en) | 2016-09-28 | 2020-03-11 | Genocea Biosciences Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF HERPES |
| MX2023008826A (es) | 2021-02-01 | 2023-09-15 | Regenxbio Inc | Terapia génica para lipofuscinosis neuronal ceroidea. |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4394448A (en) | 1978-02-24 | 1983-07-19 | Szoka Jr Francis C | Method of inserting DNA into living cells |
| US4241046A (en) | 1978-11-30 | 1980-12-23 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
| US5036006A (en) | 1984-11-13 | 1991-07-30 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| DK0737750T3 (da) | 1989-03-21 | 2003-09-01 | Vical Inc | Ekspression af exogene polynucleotidsekvenser i vertebrater |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5676954A (en) | 1989-11-03 | 1997-10-14 | Vanderbilt University | Method of in vivo delivery of functioning foreign genes |
| US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| US5955088A (en) | 1992-02-03 | 1999-09-21 | Cedars-Sinai Medical Center | Pharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteins |
| ATE295895T1 (de) | 1992-03-11 | 2005-06-15 | Powderject Vaccines Inc | Genetischer impfstoff gegen den immunschwäche virus |
| US5593972A (en) | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
| WO1994027612A1 (en) * | 1993-05-20 | 1994-12-08 | Baylor College Of Medicine | Genetic therapy for cardiovascular disease |
| US5614503A (en) | 1993-11-12 | 1997-03-25 | Aronex Pharmaceuticals, Inc. | Amphipathic nucleic acid transporter |
| US5739118A (en) | 1994-04-01 | 1998-04-14 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
| WO1995033835A1 (en) * | 1994-06-02 | 1995-12-14 | Chiron Corporation | Nucleic acid immunization using a virus-based infection/transfection system |
| US5837533A (en) | 1994-09-28 | 1998-11-17 | American Home Products Corporation | Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent |
| IT1270123B (it) * | 1994-10-05 | 1997-04-28 | Dompe Spa | Composizioni farmaceutiche contenenti microorganismi ingegnerizzati e loro uso per terapia |
| US5707618A (en) | 1995-03-24 | 1998-01-13 | Genzyme Corporation | Adenovirus vectors for gene therapy |
| US5756283A (en) | 1995-06-05 | 1998-05-26 | The Trustees Of The University Of Pennsylvania | Method for improved production of recombinant adeno-associated viruses for gene therapy |
| JP2002514056A (ja) | 1996-10-23 | 2002-05-14 | アメリカン・ホーム・プロダクツ・コーポレーション | ワクチン |
| WO1999043839A1 (en) * | 1998-02-27 | 1999-09-02 | The Trustees Of The University Of Pennsylvania | Vaccines, immunotherapeutics and methods for using the same |
-
2001
- 2001-07-27 DE DE60131975T patent/DE60131975T2/de not_active Expired - Fee Related
- 2001-07-27 JP JP2002516326A patent/JP2004505113A/ja not_active Abandoned
- 2001-07-27 AU AU8467201A patent/AU8467201A/xx active Pending
- 2001-07-27 AU AU2001284672A patent/AU2001284672B2/en not_active Ceased
- 2001-07-27 WO PCT/US2001/023648 patent/WO2002010410A1/en not_active Ceased
- 2001-07-27 US US10/333,802 patent/US7569218B2/en not_active Expired - Lifetime
- 2001-07-27 CA CA002417364A patent/CA2417364A1/en not_active Abandoned
- 2001-07-27 AT AT01963746T patent/ATE381351T1/de not_active IP Right Cessation
- 2001-07-27 EP EP01963746A patent/EP1305435B1/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL217317A0 (en) | Nucleic acid and corresponding protein entitled 161p2f10b and pharmaceutical and diagnostic compositions containing the same and uses thereof | |
| IL161268A0 (en) | Nucleic acid and corresponding protein entitled 161p2f10b and pharmaceutical and diagnostic compositions containing the same | |
| WO2004084805A3 (en) | Acetylated tat polypeptides and methods of use thereof | |
| EP1741782A8 (en) | Immunogenic polypeptides encoded by MAGE minigenes and uses thereof | |
| WO2002053703A3 (en) | Aav2 vectors and methods | |
| LU92749I2 (fr) | Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2) | |
| IS6378A (is) | Efnasambönd og samsetningar gegn dvergveirum, notkun þeirra til lyfjagerðar og efni til að framleiða þau | |
| WO2004087062A3 (en) | Compositions and methods involving respiratory syncytial virus subgroup b strain 9320 | |
| IL158293A (en) | Nucleic acid and corresponding protein entitled 158p3d2 and pharmaceutical compositions containing the same | |
| DE60131975D1 (de) | Anwendung des herpes simplex virus glykoproteins-d zur unterdrückung von immunantworten | |
| DE60037263D1 (de) | Virus-ähnliche Partikel, ihre Herstellung und ihre Verwendung beim pharmazeutischen Screening und funktionelle Genomanwendungen | |
| JP2005535281A5 (enExample) | ||
| CA2073282A1 (en) | Human herpesvirus type 6 protein p100, the corresponding dna sequences, their preparation and use | |
| WO2002070557A3 (en) | Nuclear hormone receptor ligand binding domain | |
| AU2002256019A8 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
| IL160651A (en) | Nucleic acid and corresponding protein entitled 205pib5 and pharmaceutical compositions containing the same and uses thereof | |
| AU2003303889A8 (en) | Polypeptides f' of the hepatitis c virus, epitopes, and the diagnostic and therapeutic applications thereof | |
| RU2001127052A (ru) | Штамм вируса Эбола "Заир Ч-15" для проведения модельных экспериментов и приготовления диагностических и вакцинных препаратов | |
| Healy | The Dramatic Encounter of Divine and Human Freedom in the Theology of Hans Urs von Balthasar | |
| WO2002070561A3 (en) | Nuclear hormone receptor ligand binding domain | |
| WO2004001425A3 (en) | Mhc class ii haplotype specific immunodominancy of peptides derived from rsv fusion (f) and attachement (g) proteins | |
| WO1998031796A8 (en) | Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons | |
| AU2003217864A8 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
| Costa | Computational studies of the structure/function relation of proteins involved in neurotransmission and neurotransduction in excitable cells: nAChR and Ca2+-ATPase | |
| JP2003139751A5 (enExample) |